pimagedine has been researched along with Leukemia P388 in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Millican, SA | 1 |
| Bagga, M | 1 |
| Eddy, R | 1 |
| Mitchinson, MJ | 1 |
| Hunt, JV | 1 |
1 other study available for pimagedine and Leukemia P388
| Article | Year |
|---|---|
Effect of glucose-mediated LDL oxidation on the P388D1 macrophage-like cell line.
Topics: Animals; Cell Survival; Chromatography, Gas; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitor | 1997 |